The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Radioisotope Renography

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Radioisotope Renography


High impact information on Radioisotope Renography


Chemical compound and disease context of Radioisotope Renography


Biological context of Radioisotope Renography


Anatomical context of Radioisotope Renography


Associations of Radioisotope Renography with chemical compounds

  • After the initial urogram, sequential DTPA scanning and renography are sufficient for follow-up [24].
  • The study also demonstrated that furosemide will significantly and predictably influence renography and the pertechnetate study [25].
  • I-125 Hippuran renography was performed before clamping, immediately after clamp release, and at 2, 4, 6, and 14 days later [26].
  • Interrupting the vasoactive action of angiotensin II alone on the efferent glomerular arteries, which can also be selectively achieved by chronic administration of angiotensin II receptor antagonists, does not fully explain the effectiveness of captopril renography in detecting renovascular hypertensive patients [9].
  • Subgroup analysis of modest (50-75%) and severe (> or =75%) RAS, or of plasma creatinine greater than 120 micromol/L, also showed no difference between captopril and aspirin renography [14].

Gene context of Radioisotope Renography

  • Procedure guideline for diuretic renography in children. Society of Nuclear Medicine [27].
  • Reliability of captopril renography in patients under chronic therapy with angiotensin II (AT1) receptor antagonists [9].
  • With further experience, renography may become a useful tool for predicting postoperative outcome in ischemic CM [28].
  • 99mTc-DTPA renography and plasma renin activity measurements were performed before and after an oral dose of 50 mg captopril [29].
  • Patients were excluded from review when they had bilateral ureteropelvic junction obstruction, a solitary kidney, associated vesicoureteral reflux, or other bladder or ureteral abnormalities, and when preoperative and postoperative renography studies were not available [30].

Analytical, diagnostic and therapeutic context of Radioisotope Renography


  1. Furosemide augments the effects of captopril on nuclear studies in renovascular stenosis. Kopecky, R.T., Thomas, F.D., McAfee, J.G. Hypertension (1987) [Pubmed]
  2. Simplified captopril renography in diagnosis and treatment of renal artery stenosis. Setaro, J.F., Saddler, M.C., Chen, C.C., Hoffer, P.B., Roer, D.A., Markowitz, D.M., Meier, G.H., Gusberg, R.J., Black, H.R. Hypertension (1991) [Pubmed]
  3. [131I] Hippuran renography in the detection of orthostatic hypertension. Clorius, J.H., Kjelle-Schweigler, M., Ostertag, H., Möhring, K. J. Nucl. Med. (1978) [Pubmed]
  4. Interobserver agreement on captopril renography for assessing renal vascular disease. Krijnen, P., Oei, H.Y., Claessens, R.A., Roos, J.C., van Jaarsveld, B.C., Habbema, J.D. J. Nucl. Med. (2002) [Pubmed]
  5. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. MacDowall, P., Kalra, P.A., O'Donoghue, D.J., Waldek, S., Mamtora, H., Brown, K. Lancet (1998) [Pubmed]
  6. Furosemide-131I-hippuran renography after angiotensin-converting enzyme inhibition for the diagnosis of renovascular hypertension. Erbslöh-Möller, B., Dumas, A., Roth, D., Sfakianakis, G.N., Bourgoignie, J.J. Am. J. Med. (1991) [Pubmed]
  7. Differential renal function during angiotensin converting enzyme inhibition in renovascular hypertension. Jackson, B., McGrath, B.P., Matthews, P.G., Wong, C., Johnston, C.I. Hypertension (1986) [Pubmed]
  8. Three-dimensional conformal radiotherapy for localized prostate cancer in kidney transplant recipients. Mouzin, M., Bachaud, J.M., Kamar, N., Gamé, X., Vaessen, C., Rischmann, P., Rostaing, L., Malavaud, B. Transplantation (2004) [Pubmed]
  9. Reliability of captopril renography in patients under chronic therapy with angiotensin II (AT1) receptor antagonists. Picciotto, G., Sargiotto, A., Petrarulo, M., Rabbia, C., De Filippi, P.G., Roccatello, D. J. Nucl. Med. (2003) [Pubmed]
  10. Diagnostic use of angiotensin converting enzyme inhibitors in radioisotope evaluation of unilateral renal artery stenosis. Kremer Hovinga, T.K., de Jong, P.E., Piers, D.A., Beekhuis, H., van der Hem, G.K., de Zeeuw, D. J. Nucl. Med. (1989) [Pubmed]
  11. Captopril MR renography in a swine model: toward a comprehensive evaluation of renal arterial stenosis. Prasad, P.V., Goldfarb, J., Sundaram, C., Priatna, A., Li, W., Edelman, R.R. Radiology. (2000) [Pubmed]
  12. Enalaprilat-enhanced renography in a rat model of renovascular hypertension. Kopecky, R.T., McAfee, J.G., Thomas, F.D., Anderson, G.H., Hellwig, B., Roskopf, M., Patchin, D. J. Nucl. Med. (1990) [Pubmed]
  13. Steady-state captopril renography: continuous monitoring of the captopril-induced increase in 99mTc-MAG3 mean parenchymal transit time in renovascular hypertension. Esper, I.E., Chajari, M., Fonroget, J., Neveu, J.P., Makdassi, R., Bailly, P., Fournier, A. European journal of nuclear medicine. (1997) [Pubmed]
  14. Aspirin renography and captopril renography in the diagnosis of renal artery stenosis. van de Ven, P.J., de Klerk, J.M., Mertens, I.J., Koomans, H.A., Beutler, J.J. J. Nucl. Med. (2000) [Pubmed]
  15. Interpretation of captopril renography by nuclear medicine physicians. Schreij, G., van Kroonenburgh, M.J., Heidendal, G.K., van der Pol, H.A., de Leeuw, P.W. J. Nucl. Med. (1995) [Pubmed]
  16. False-positive captopril renography in patients taking calcium antagonists. Claveau-Tremblay, R., Turpin, S., De Braekeleer, M., Brassard, A., Leblond, R. J. Nucl. Med. (1998) [Pubmed]
  17. Radionuclide captopril renography in postpartum renal artery aneurysms. Turpin, S., Lambert, R., Querin, S., Soulez, G., Leveille, J., Taillefer, R. J. Nucl. Med. (1996) [Pubmed]
  18. Renal function outcome in unilateral hydronephrosis in newborn pigs. II. Function and volume of contralateral kidneys. Eskild-Jensen, A., Jacobsen, L., Christensen, H., Frøkiaer, J., Jørgensen, H.S., Djurhuus, J.C., Jørgensen, T.M. J. Urol. (2001) [Pubmed]
  19. Diagnosis and evaluation of renovascular hypertension. Indications for therapy. Pickering, T.G. Circulation (1991) [Pubmed]
  20. Extravascular chest wall technetium 99m diethylene triamine penta-acetic acid: implications for the measurement of renal function during renography. Bell, S.D., Peters, A.M. European journal of nuclear medicine. (1991) [Pubmed]
  21. Study of bilharzial uropathy by means of hippuran I131 extended renography. Zahran, M.M., Badr, M.M. Am. J. Trop. Med. Hyg. (1980) [Pubmed]
  22. Diuresis renography in patients with reduced renal function. Hjortsø, E., Fugleberg, S., Nielsen, L., Gjørup, T., Hartling, O., Munck, O. Danish medical bulletin. (1988) [Pubmed]
  23. Application of radioisotope renography with technetium-99m mercaptoacetyltriglycine on patients with spinal cord injuries. Bih, L.I., Changlai, S.P., Ho, C.C., Lee, S.P. Archives of physical medicine and rehabilitation. (1994) [Pubmed]
  24. Radionuclide studies of chronic schistosomal uropathy. Lamki, L.M., Lamki, N. Radiology. (1981) [Pubmed]
  25. Renal graft evaluation with pertechnetate and I-131 Hippuran. A comparative clinical study. Clorius, J.H., Dreikorn, K., Zelt, J., Raptou, E., Weber, D., Rubinstein, K., Dahm, D., Georgi, P. J. Nucl. Med. (1979) [Pubmed]
  26. Renographic evaluation of kidney preservation with chlorpromazine. Dahlager, J.I., Bilde, T. J. Nucl. Med. (1979) [Pubmed]
  27. Procedure guideline for diuretic renography in children. Society of Nuclear Medicine. Mandell, G.A., Cooper, J.A., Leonard, J.C., Majd, M., Miller, J.H., Parisi, M.T., Sfakianakis, G.N. J. Nucl. Med. (1997) [Pubmed]
  28. Renography before heart transplantation in patients with cardiomyopathy. Aigner, R.M., O'Mara, R.E., Fueger, G.F., Tscheliessnigg, K., Nicoletti, R., Sorantin, E., Smith, E.M. J. Nucl. Med. (1998) [Pubmed]
  29. Evidence for a renovascular component in hypertensive patients with late radiation nephropathy. Verheij, M., Dewit, L.G., Valdés Olmos, R.A., Arisz, L. Int. J. Radiat. Oncol. Biol. Phys. (1994) [Pubmed]
  30. Renal function before and after pyeloplasty: does it improve? McAleer, I.M., Kaplan, G.W. J. Urol. (1999) [Pubmed]
  31. Captopril-induced changes in MAG3 clearance in patients with renal arterial stenosis and the effect of renal angioplasty. Müller-Suur, R., Tidgren, B., Fehrm, A., Lundberg, H.J. J. Nucl. Med. (2000) [Pubmed]
  32. Abdominal aortic aneurysms: treatment with juxtarenal placement of covered stent-grafts. Duda, S.H., Raygrotzki, S., Wiskirchen, J., Khalighi, K., Schott, U., Bares, R., Ziemer, G., Claussen, C.D. Radiology. (1998) [Pubmed]
  33. Cost efficacy of the diagnosis and therapy of renovascular hypertension. Blaufox, M.D., Middleton, M.L., Bongiovanni, J., Davis, B.R. J. Nucl. Med. (1996) [Pubmed]
WikiGenes - Universities